Free Trial

Chris Markoch, Editor & Contributing Author at MarketBeat

Articles by Chris Markoch - Page 21

Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
October 18, 2022 11:21 PM ET

Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?

Chris Markoch

JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain

NYSE:JNJNYSE:ABTNYSE:ABBV
Read Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
Another Relief Rally? Here’s a Playbook for Traders and Investors
October 18, 2022 9:00 AM ET

Another Relief Rally? Here’s a Playbook for Traders and Investors

Chris Markoch

Equities are staging a relief rally on better-than-expected earnings. This article gives active traders and buy-and-hold investors tips on what to do now

Read Another Relief Rally? Here’s a Playbook for Traders and Investors
Fisker is Entering a Critical Stage That Could Reward Investors
October 17, 2022 9:00 AM ET

Fisker is Entering a Critical Stage That Could Reward Investors

Chris Markoch

Fisker is starting to delivery on its hype, and risk-tolerant investors with time to wait may get a nice payoff from FSR stock

NYSE:FSRNYSE:FNYSE:GM
Read Fisker is Entering a Critical Stage That Could Reward Investors
Should Investors Look to Bag Shares of Kroger’s or Albertson’s?
October 16, 2022 11:21 PM ET

Should Investors Look to Bag Shares of Kroger’s or Albertson’s?

Chris Markoch

Despite the potential benefits, the proposed Kroger/Albertsons merger faces regulatory scrutiny. Is now the time to invest in either of the two companies

NYSE:KRNYSE:ACINYSE:WMT
Read Should Investors Look to Bag Shares of Kroger’s or Albertson’s?
United Health Group Continues to Justify a Premium Valuation
October 16, 2022 11:00 PM ET

United Health Group Continues to Justify a Premium Valuation

Chris Markoch

At a time when investors are seeking value wherever they can find it, UnitedHealth Group is offering investors both growth and value

NYSE:UNHNYSE:CINASDAQ:CHNG
Read United Health Group Continues to Justify a Premium Valuation
The Rally in Walgreen’s Boots Alliance May be Short Lived
October 13, 2022 11:00 PM ET

The Rally in Walgreen’s Boots Alliance May be Short Lived

Chris Markoch

Walgreen's Boots Alliance is up sharply after posting a double beat. But with growth remaining sluggish, this current bump in WBA stock mayl be short lived

NASDAQ:WBA
Read The Rally in Walgreen’s Boots Alliance May be Short Lived
Constellation Brands Stock May Offer Safety in the Market Storm
October 13, 2022 8:00 AM ET

Constellation Brands Stock May Offer Safety in the Market Storm

Chris Markoch

Investors who are looking to ride out the bear market may want to take a close look at Constellation Brands as a defensive stock with refreshing guidance

NYSE:STZNASDAQ:CGC
Read Constellation Brands Stock May Offer Safety in the Market Storm
McCormick May Get Spicy if it Improves Earnings
October 11, 2022 7:00 AM ET

McCormick May Get Spicy if it Improves Earnings

Chris Markoch

We break down McCormick's latest earnings report and why the forward guidance may make MKC stock a worthwhile hold for income-oriented investors

NYSE:MKC
Read McCormick May Get Spicy if it Improves Earnings
FAQ: U.S. Bond Market Holidays and Hours 2023
October 9, 2022 11:00 PM ET

FAQ: U.S. Bond Market Holidays and Hours 2023

Chris Markoch

This article answers some of the most commonly asked questions regarding the bond market. We'll also look at factors to consider before investing in bonds. 

Read FAQ: U.S. Bond Market Holidays and Hours 2023
Lucid Motors May Test Investors Resolve, But Should They Sell?
October 6, 2022 11:00 PM ET

Lucid Motors May Test Investors' Resolve, But Should They Sell?

Chris Markoch

Macroeconomic realities are weighing on the near-term outlook for all EV companies. This article will examine if you should continue to hold onto Lucid Motors

NASDAQ:LCID
Read Lucid Motors May Test Investors' Resolve, But Should They Sell?
Is Fords Revenue Enough to Juice its Stock Price?
October 6, 2022 9:00 AM ET

Is Ford's Revenue Enough to Juice its Stock Price?

Chris Markoch

Although EV sales are on the rise, the overall revenue picture may leave investors skeptical of the recent Ford stock jolt.

NYSE:FNYSE:MS
Read Is Ford's Revenue Enough to Juice its Stock Price?
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
October 5, 2022 11:21 PM ET

3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up

Chris Markoch

Here is a look at three names that buy-and-hold investors may want to consider as the race to find a cure for Alzheimer's disease accelerates

NASDAQ:BIIBNYSE:LLYNASDAQ:SAVA
Read 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
October 5, 2022 11:00 PM ET

Rivian Checks Off Boxes, But Still Needs a Lot to Go Right

Chris Markoch

Despite positive production news that gave RIVN stock a quick boost, the stock is struggling to hold those gains as macroeconomic issues take center stage

NASDAQ:RIVNNASDAQ:AMZNNYSE:F
Read Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
October 5, 2022 8:00 AM ET

Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear

Chris Markoch

Will Rite Aid stock ever recover? Unless Rite Aid can improve its revenue, the best advice for investors may involve staying away from the stock.

NYSE:RADNASDAQ:WBA
Read Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
Declining Profits Challenge the CarMax Value Proposition
September 30, 2022 4:05 AM ET

Declining Profits Challenge the CarMax Value Proposition

Chris Markoch

A steep decline in CarMax profits shows that a more efficient way to sell cars is not enough to overcome higher prices that are keeping consumers away

NYSE:KMXNYSE:AN
Read Declining Profits Challenge the CarMax Value Proposition
What Cintas Can Teach Investors About This Bear Market?
September 29, 2022 8:00 AM ET

What Cintas Can Teach Investors About This Bear Market?

Chris Markoch

This article will explore a few reasons why Cintas may be a good option for long-term investors, and why there may be better options for short-term traders

NASDAQ:CTAS
Read What Cintas Can Teach Investors About This Bear Market?
Can United Natural Foods Fight Both Inflation and the Fed?
September 28, 2022 10:00 AM ET

Can United Natural Foods Fight Both Inflation and the Fed?

Chris Markoch

UNFI stock is down 26% for the year despite solid earnings. In this article, I’ll look at what may be driving the stock lower and if it's a watchlist candidate

NYSE:UNFI
Read Can United Natural Foods Fight Both Inflation and the Fed?
How to Effectively Use the MarketBeat Ratings Screener
September 25, 2022 11:00 PM ET

How to Effectively Use the MarketBeat Ratings Screener

Chris Markoch

The MarketBeat Ratings Screener gives investors a one-stop resource to search for any analyst rating issued for any quarter going back before the year 2000

NYSE:BACNYSE:CNYSE:WMT
Read How to Effectively Use the MarketBeat Ratings Screener
Insider Trades May Not Tell You What You Think
September 22, 2022 11:00 PM ET

Insider Trades May Not Tell You What You Think

Chris Markoch

This article focuses on the MarketBeat insider transactions screener and explains how investors can use it to supplement their research

NASDAQ:MSFT
Read Insider Trades May Not Tell You What You Think
What Steelcases Earnings Say About the Return to the Office?
September 22, 2022 8:00 AM ET

What Steelcase's Earnings Say About the Return to the Office?

Chris Markoch

This article looks at what Steelcase said in its earnings report and why it could be a leading indicator of what is coming for the next several quarters. 

NYSE:SCSNASDAQ:MLKN
Read What Steelcase's Earnings Say About the Return to the Office?
Target stock
September 21, 2022 11:23 PM ET

The Worst May be Over for Target, But is the Stock Safe to Buy?

Chris Markoch

Investors may be debating if they should hold TGT stock during this market downturn. This article explains why long-term investors may want to do just that

NYSE:TGTNYSE:WMT
Read The Worst May be Over for Target, But is the Stock Safe to Buy?
Novavax Stock
September 21, 2022 11:00 PM ET

Novavax Remains a Risk-On Stock in a Risk-Off Market

Chris Markoch

NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors

NASDAQ:NVAXNYSE:PFENASDAQ:MRNA
Read Novavax Remains a Risk-On Stock in a Risk-Off Market
How to Most Effectively Use the MarketBeat Earnings Screener
September 20, 2022 11:00 PM ET

How to Most Effectively Use the MarketBeat Earnings Screener

Chris Markoch

This article focuses on the MarketBeat earnings screener and explains how investors can use this tool to refine and/or provide a shortcut for their research

NASDAQ:AMZNNASDAQ:AAPL
Read How to Most Effectively Use the MarketBeat Earnings Screener
The Significance of Brokerage Rankings in Stock Selection
September 18, 2022 11:00 PM ET

The Significance of Brokerage Rankings in Stock Selection

Chris Markoch

This article defines the role of sell-side analysts who work at brokerage houses, what their ratings mean, and why these ratings matter to investors

Read The Significance of Brokerage Rankings in Stock Selection